文献速递青光眼

原发性房角关闭进展相关因素:ANA-LIS试验事后分析

Factors Associated With Progression to Primary Angle Closure: A Post Hoc Analysis of the ANA-LIS Trial.
PubMed 文献 · JAMA Ophthalmol · 2026-01-01

该研究为ANA-LIS随机临床试验的事后分析,评估基线眼前节风险因素与可疑原发性房角关闭(PACS)向原发性房角关闭(PAC)进展的关联。480名参与者中161人(33.5%)接受基线AS-OCT和UBM检查,322眼中16眼(5.0%)进展。多变量模型显示基线眼压较高、UBM显示更多象限的虹膜高褶以及TISA750较小与进展风险增加独立相关。

要点

  • 基线眼压每升高1 mmHg,进展风险增加(OR 1.6)。
  • UBM显示虹膜高褶象限数每增加1个,进展风险增加(OR 4.5)。
  • TISA750每减少0.1 mm²或存在≥1象限虹膜高褶,进展风险显著增加。

核心结论

  • 更窄的前房角、超过1个象限的虹膜高褶构型或较高的基线眼压与PACS向PAC进展风险增加相关。

研究设计与样本

  • 新加坡无症状窄角激光虹膜切开术研究(ANA-LIS)的事后分析,纳入480名参与者,其中161人(33.5%)接受基线AS-OCT和UBM检查,共322眼。

主要发现

  • 322眼中16眼(5.0%)进展,其中7眼接受LPI,9眼未接受LPI。

关键数值与推荐

  • PACS诊断标准为非压陷房角镜下色素性小梁网在≥2个象限不可见。
  • 进展定义为发生PAC(眼压>24 mmHg和/或≥1钟点周边虹膜前粘连,或急性房角关闭发作)。

临床怎么用

  • 对于PACS患者,可结合基线眼压、UBM虹膜高褶象限数和AS-OCT TISA750评估进展风险。
  • 存在多象限虹膜高褶或TISA750较小的PACS眼可能需更密切随访。

局限性

  • 仅33.5%的原始参与者接受基线AS-OCT和UBM检查,样本量有限。
  • 为事后分析,结果需在更多人群中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Identifying primary angle closure suspect (PACS) eyes at higher risk of progressing to primary angle closure (PAC) is clinically important. OBJECTIVE: To evaluate baseline anterior segment risk factors associated with progression from PACS to PAC over 5 years. DESIGN, SETTING, PARTICIPANTS: This post hoc analysis involves data from a randomized clinical trial (Singapore Asymptomatic Narrow Angles-Laser Iridotomy Study) conducted at 5 tertiary eye hospitals from November 1, 2004, to October 31, 2018. The original enrollment included 480 participants. Data analysis for this report was conducted from May to July 2025. INTERVENTIONS: All participants underwent comprehensive ocular examinations, including anterior segment optical coherence tomography (AS-OCT) and ultrasound biomicroscopy (UBM) at baseline, before laser peripheral iridotomy (LPI), and LPI in 1 randomly selected eye. PACS was diagnosed if the pigmented trabecular meshwork was not visualized for 2 or more quadrants on nonindentation gonioscopy. MAIN OUTCOME AND MEASURES: Progression was defined as development of PAC (intraocular pressure [IOP] >24 mm Hg and/or ≥1 clock hour of peripheral anterior synechiae, or an episode of acute angle closure). Risk factors for progression were assessed using univariable and multivariable generalized linear models (GLMs) with generalized estimating equations and Cox regression models clustered by participant. We estimated odds ratios (ORs) with 95% CI using GLM and hazard ratios (HRs) with 95% CI using Cox regression. RESULTS: Of the 480 participants originally enrolled, 161 (33.5%) underwent baseline AS-OCT and UBM. Among these participants, 123 (76.4%) were female and 38 (23.6%) male; the mean (SD) age was 62.9 (7.2) years. Overall, 16 of 322 eyes (5.0%, 7 with LPI and 9 without LPI) progressed. In the multivariable GLM model (area under the receiver operating characteristic curve = 0.83), higher baseline IOP (OR, 1.6 per 1 mm Hg; 95% CI, 1.2-2.1; P = .003) or a higher number of plateau iris quadrants on UBM (OR, 4.5 per quadrant; 95% CI, 1.6-13.0; P = .005) were associated with progression. In the multivariable Cox model adjusted for baseline IOP, trabecular-iris space area (TISA750; HR, 3.1 per -0.1 mm2; 95% CI, 1.3-7.5; P = .02) or the presence of plateau iris in ≥1 quadrant (HR, 11.1; 95% CI, 3.3-37.7; P = .001) were independently associated with greater risk of progression. An additional Cox model adjusting for iris curvature confirmed the associations of TISA750 (HR, 3.3; 95% CI, 1.3-8.6; P = .02) or plateau iris (HR, 12.5; 95% CI, 3.8-40.4; P < .001) with progression. CONCLUSIONS AND RELEVANCE: Narrower anterior chamber angles, plateau iris configuration in more than 1 quadrant, or higher baseline IOP were associated with greater risk of progression. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT00347178.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Tun TA, Yoo C, Servillo A, et al. Factors Associated With Progression to Primary Angle Closure: A Post Hoc Analysis of the ANA-LIS Trial. JAMA Ophthalmol. 2026. PMID: 42461625. doi:10.1001/jamaophthalmol.2026.2554

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。